Adenosine and adenine nucleotides shorten the action potential duration of atrial myocytes and activate a specific acetylcholine and adenosine receptor-operated potassium outward current referred to as IKACh,Ado The objective of this study was to determine whether adenine nucleotides shorten the action potential duration and increase IKAChAdo in guinea pig atrial myocytes by directly activating adenosine receptors. The potency and efficacy of AMP and adenosine in increasing KACh,Ado and shortening atrial action potential duration were similar; the EC50 values for AMP and adenosine were 3.4±0.8 and 3.1±0.4 ,M, respectively. Likewise, the maximum increases in IKACh,Ado caused by AMP and adenosine were similar (122±11% versus 123 ±9%). In comparison, ATP and the stable analogue of AMP, adenosine monophosphorothioate (AMPS), were significantly less potent and efficacious than adenosine and AMP, and inosine had no effect. The electrophysiological effects of AMP were antagonized by the adenosine receptor antagonist 8-(p-sulfophenyl)theophylline and abolished in the presence of adenosine deaminase and a,P-methylene-ADP (APCP, an inhibitor of AMP degradation). Binding of the A1-adenosine antagonist [3H]8-cyclopentyl-1,3-dipropylxanthine (DPCPX) to guinea pig atrial membranes treated with adenosine deaminase and APCP was reduced up to 60% by 100 ,M concentrations of AMP, AMPS, and adenosine. Inosine inhibited binding by 43 ±3% at 100 ,M, whereas hypoxanthine and xanthine had little (5-10% inhibition) and uric acid had no effect. Only 3% of AMP and 35% of AMPS were recovered intact after a 90-minute incubation at 21°C with preparations of guinea pig atrial membranes. Percent displacement of [3H]DPCPX binding to atrial membranes by 100 ,uM AMP was significantly less in the presence of nucleoside phosphorylase and xanthine oxidase (to degrade inosine, hypoxanthine, and xanthine to uric acid) than in their absence (12.4±3.1% versus 49.7±1.5%). The results suggest that the observed electrophysiological actions of adenine nucleotides in cardiomyocytes are mediated by adenosine and are consistent with activation of A1-adenosine receptors. (Circulation Research 1991;68:1035-1044 A denosine has been shown to slow heart rate and atrioventricular conduction via activation of an outward K+ current or by antagonism of catecholamine-stimulated inward calcium current and pacemaker current.1-4 These actions are initiated on activation of specific A1-adenosine receptors on the surface of the cell.
A1-adenosine antagonist [3H]8-cyclopentyl-1,3-dipropylxanthine (DPCPX) to guinea pig atrial membranes treated with adenosine deaminase and APCP was reduced up to 60% by 100 ,M concentrations of AMP, AMPS, and adenosine. Inosine inhibited binding by 43 ±3% at 100 ,M, whereas hypoxanthine and xanthine had little (5-10% inhibition) and uric acid had no effect. Only 3% of AMP and 35% of AMPS were recovered intact after a 90-minute incubation at 21°C with preparations of guinea pig atrial membranes. Percent displacement of [3H]DPCPX binding to atrial membranes by 100 ,uM AMP was significantly less in the presence of nucleoside phosphorylase and xanthine oxidase (to degrade inosine, hypoxanthine, and xanthine to uric acid) than in their absence (12 atrial myocytes and radioligand binding competition experiments for A1-adenosine receptors in bovine brain and guinea pig cardiac tissues were performed.
Materials and Methods
Adenosine, AMP, ATP, a4,-methylene-ADP (APCP), adenosine monophosphorothioate (AMPS), N6-cyclopentyladenosine (CPA), (-)-N6-(2-phenylisopropyl)adenosine (R-PIA), adenosine deaminase (ADA) type VI, and other nucleotides and nucleosides were purchased from Sigma, St Membrane Preparation Brain. Pieces of frozen bovine brain cortex (PelFreez Biologicals, Rogers, Ark.) were immediately immersed and homogenized (Polytron, Brinkmann Instruments, Westbury, N.Y.) for 10 seconds in 10 vol ice-cold buffer, pH 7.4, containing 10 mM HEPES, 10 mM EDTA, 1 mM dithiothreitol, 0.1 mM benzamidine, 10 gg/ml phenylmethylsulfonyl fluoride, and 10% (wt/vol) sucrose. The homogenate was filtered through 210-,um nylon mesh and centrifuged at 30,000g for 15 minutes at 4°C. The supernatant was discarded, and the pellet was resuspended in 10 vol of the same buffer and washed three times by centrifugation. The washed pellet was resuspended to give a protein concentration of 0.4-0.6 mg/ml in 25 mM Bis-Tris propane buffer, pH 7.4, containing 1 mM MgC12.
Heart. Guinea pig hearts were perfused for 10 minutes with oxygenated K-H solution to remove blood. After a rinse in ice-cold HEPES buffer containing 10 ,ug/ml leupeptin, atria or ventricles were isolated and homogenized (Polytron, Brinkmann Instruments) for 10 seconds in 10 vol of the same buffer, filtered through four layers of gauze, and centrifuged at 30,00(g for 15 minutes at 4°C. The supernatant was discarded, and the pellet was resuspended in 10 vol buffer and washed three times by centrifugation. The final pellet was resuspended in 50 mM Tris-HCl buffer, pH 7.4, containing 10 mM MgCl2, to give a protein concentration of 2-3 mg/ml. ments, Carlsbad, Calif.) using an automated gradient high-performance liquid chromatography system (Spectra-Physics, Inc., Bedford, Mass.) to separate and quantitate adenosine, inosine, AMP, or AMPS.20 AMP and adenosine contents of samples were confirmed by collecting the AMP or adenosine fraction of the column eluate, converting AMP to adenosine with 5'-nucleotidase and adenosine to inosine with ADA, and quantitating the adenosine and inosine formed, by use of an isocratic high-performance liquid chromatography method.20
Protein Assay Protein contents of membrane preparations were determined according to the method of Bradford21 using a protein assay kit (Bio-Rad, Richmond, Calif.) with bovine serum albumin as standard.
Data Analysis
The concentrations of adenosine, AMP, AMPS, Therefore, additional competition experiments were carried out. Inosine at high concentration (100 ,uM) was able to compete with [3H]DPCPX (4 nM) for binding to guinea pig atrial membranes (57+3% of control; p<O.O1 [ Figure 11] Inhibition of the degradation of AMP to adenosine and acceleration of the degradation of adenosine to inosine markedly reduced the effect of AMP on atrial cell electrophysiology. Also, the potencies and efficacies of both ATP and AMPS (which degrade more slowly than AMP to adenosine) in activating KACh,Ado and shortening the atrial action potential duration were less than those of AMP. The results suggest that the similar electrophysiological effects of adenine nucleotides and adenosine on atrial myocytes can be explained by enzymatic degradation of the former with concurrent accumulation of the latter. This conclusion is consistent with our previous study8 of the effects of ATP on atrioventricular node conduction in an isolated perfused guinea pig heart preparation. In that earlier study, it was found that the negative dromotropic action of ATP was dependent on a rapid degradation of ATP to adenosine. Altogether the results from both electrophysiological and binding studies are consistent with the hypothesis that adenine nucleotides and purines, except for adenosine, do not bind and/or activate the cardiac A1-adenosine receptor in atrial myocytes. This interpretation is limited by the fact that none of the approaches in the present study was completely successful in preventing degradation of adenine nucleotides. The presence of a wide spectrum of adenine nucleotide degradative enzymes in most commonly used cellular and membrane preparations poses serious difficulties to evaluate the "true" effects, not to mention the potency and efficacy, of adenine nucleotide actions. Thus, the interpretation of physiological and pharmacological studies of adenine nucleotides must be done with great caution.
